Donepezil Double Blind Trial for ECT Memory Disfunction
NCT ID: NCT00465283
Last Updated: 2009-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2007-05-31
2010-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients will be randomized to receive either donezepil or plasebo, in order to gauge whether donezepil has a protective effect on memory disfunction, while patients are treated with ECT. Several parameters will be invistigated at baseline: general psychopathological measures, memory function scales, side effects scales. The same measurements will be taken throughout the trial and one month after ending the ECT.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323
A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia
NCT01490567
This Study Tests Whether BI 425809 Together With Brain Training Using a Computer Improves Mental Functioning in Patients With Schizophrenia
NCT03859973
The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics
NCT00986531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Donepezil
Donepezil
Tab.Donepezil 5 mg once daily during ECT treatment and the month after the last ECT treatment
placebo
Donepezil
Tab.Donepezil 5 mg once daily during ECT treatment and the month after the last ECT treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Donepezil
Tab.Donepezil 5 mg once daily during ECT treatment and the month after the last ECT treatment
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant women
* Patients who recieved ECT within 6 month
* Patients whith contraindication to Donepezil treatment.
* Patients with Lithium treatment
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BeerYaakov Mental Health Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
BeerYaakov Mental Health Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tali Nachshoni, MD
Role: PRINCIPAL_INVESTIGATOR
Beer Yaakov Mental Health Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beer Yaakov MHC
Beer Yaacov, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Donepezil-180CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.